Sweden-based Camfil, a manufacturer of premium clean air solutions, has expanded its Manesar facility in India with a new production line for HEPA and ULPA filters, boosting supply capacity for hospitals, pharmaceutical cleanrooms, biotechnology labs, and other high-containment facilities.

According to the company, the new machinery is engineered to meet and exceed the stringent requirements of EN 1822 and ISO 29463, integrating advanced scanning and classification technologies to ensure uncompromising quality and performance. Each filter produced will be accompanied by a 100 percent individual scan test report, validating efficiency, integrity, and compliance with global standards.

Camfil highlighted its “owning our own destiny” approach, where all scanning tech and production equipment for HEPA filters are designed in-house at global R&D centers, ensuring IP control, quality assurance, and customisation flexibility.

“This step strengthens our ability to protect patients, researchers, and production processes that depend on clean air. By combining rigorous testing with greater production capacity, we are ready to support critical sectors in India and beyond,” said Mark Simmons, CEO, Camfil Group.

The new line is capable of producing a wide range of HEPA and ULPA filters tailored to Class ISO 5–ISO 8 environments, with applications spanning hospital operating theatres and isolation wards; pharmaceutical production and R&D; biotech and semiconductor cleanrooms, and BSL-rated containment zones.

“Adding this line in Manesar shows our confidence in India’s growing demand for high-performance filtration. Together with our local team, we aim to provide more customers with the clean air they need to work safely and efficiently,” said Rahul Kapoor, Managing Director, Camfil India.

With this expansion, Camfil said it is better positioned to deliver tested, certified filters for sectors where air quality is critical to health, safety, and performance.

Headquartered in Stockholm, Sweden, Camfil Group has 30 manufacturing sites, six R&D centres, and local sales offices in over 35 countries.